SCHEMBL9243240

SCHEMBL9243240

CNC(=O)NNc1ccncc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 1/20 0.52
CTSD P07339 1/20 0.50
TAAR1 Q96RJ0 2/20 0.46
RAB9A P51151 1/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TYK2 P29597 2/20 0.42
ALDH1A1 P00352 1/20 0.42
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
EPHX1 P07099 1/20 0.41
TP53 P04637 1/20 0.40
TSHR P16473 2/20 0.40
BCHE P06276 1/20 0.40
CYP3A4 P08684 1/20 0.39
ALOX5 P09917 1/20 0.39
JAK2 O60674 1/20 0.39
SMARCA2 P51531 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9461499 0.79 ALOX5 (0.63) KDM4EALDH1A1SMN1; SMN2EPHX1TP53
SCHEMBL7789976 0.79 MDM2 (0.75) MDM2TAAR1RAB9AKMT2AMEN1
SCHEMBL27802114 0.77 CTSD (0.56) MDM2CTSDTAAR1KMT2AMEN1
SCHEMBL9004626 0.75 CTSD (0.54) MDM2CTSDTAAR1KMT2AMEN1
SCHEMBL9121193 0.74 ALDH1A1 (0.73) KDM4EL3MBTL1ALDH1A1PKMSMN1; SMN2
Hydrochloric Acid SCHEMBL28030454 0.73 CTSD (0.52) MDM2CTSDTAAR1KMT2AMEN1
SCHEMBL3505987 0.71
SCHEMBL10758878 0.71 MDM2 (0.55) MDM2TAAR1RAB9AKMT2AMEN1
SCHEMBL27658590 0.71 CYP17A1 (0.50) MDM2CTSDRAB9AKMT2AMEN1
Bicarbonate SCHEMBL23093808 0.70 MDM2 (0.54) MDM2CTSDTAAR1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436252-A Antiischemic agents, stroke, Alzheimer's or Parkinson's diseases MERRELL DOW PHARMACEUTICALS INC. (US) 1995-07-25 US disclosed
EP-0273310-B1 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants MERRELL DOW PHARMA (US) 1995-06-21 EP disclosed
EP-0273309-B1 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders MERRELL DOW PHARMA (US) 1995-01-11 EP disclosed
EP-0273310-A2 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants MERRELL PHARMACEUTICALS INC. (US) 1988-07-06 EP disclosed
EP-0273309-A2 5-Aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders MERRELL DOW PHARMACEUTICALS INC. (US) 1988-07-06 EP disclosed